XML 40 R30.htm IDEA: XBRL DOCUMENT v3.24.3
Organization and Summary of Significant Accounting Policies (Tables)
 9 Months Ended
Sep. 30, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Schedule of weighted average number of shares outstanding and earnings per share The calculation of the weighted average number of shares outstanding and earnings per share are as follows (in thousands except per share data):
Three Months Ended September 30,Nine Months Ended September 30,
2024202320242023
Numerator for basic and diluted earnings per share:
Net income$67,025 $61,309 $241,850 $118,722 
Denominator:    
Weighted average shares outstanding75,697 74,826 75,543 73,904 
Dilutive effect of stock-based awards1,317 1,126 1,298 1,308 
Dilutive effect of 2027 Notes1,015 — 773 — 
Dilutive effect of 2027 Warrants51 — — — 
Diluted weighted average shares outstanding78,080 75,952 77,614 75,212 
Net income per common share:
Basic$0.89 $0.82 $3.20 $1.61 
Diluted$0.86 $0.81 $3.12 $1.58 
Schedule of potentially dilutive securities excluded in calculation of diluted net income per share
Potentially dilutive securities that are not included in the calculation of diluted net income per share because doing so would be antidilutive are as follows (in thousands):
Three Months Ended September 30,Nine Months Ended September 30,
2024202320242023
Stock-based awards4,574 481 4,620 470 
2027 Notes2,002 3,017 2,244 3,017 
2027 Warrants2,966 3,017 3,017 3,017 
Total potentially dilutive securities9,542 6,515 9,881 6,504 
Summary of changes in our estimated warranty reserve
Changes in our estimated product warranty liabilities were as follows (in thousands):
Nine Months Ended September 30,
20242023
Balance, beginning of period$7,374 $811 
Utilization of reserve(5,007)(901)
Warranty expense4,860 3,381 
Balance, end of period$7,227 $3,291